Anaptysbio Inc
(ANAB)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ANAB | AZN | AMGN | GILD | BMY |
| Company | Anaptysbio Inc | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NYSE |
| Open | 55.30 | 202.52 | 366.66 | 153.42 | 60.00 |
| High | 56.07 | 205.86 | 370.88 | 155.73 | 60.93 |
| Low | 51.92 | 202.10 | 365.06 | 150.82 | 59.25 |
| Latest | 54.90 | 204.52 | 366.20 | 151.81 | 59.86 |
| Change | -0.35 | -0.24 | -0.38 | -3.99 | -0.07 |
| % Change | -0.63% | -0.12% | -0.10% | -2.56% | -0.12% |
| Volume | 705,300 | 2,723,900 | 2,374,400 | 9,891,200 | 14,021,400 |
| 20-Day Average Volume | 441,905 | 4,620,640 | 3,221,985 | 8,919,229 | 13,729,350 |
| Previous Close | 55.25 | 204.76 | 366.58 | 155.80 | 59.93 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 48.87 | 188.74 | 351.49 | 140.36 | 56.84 |
| 20-Day Raw Stochastic | 87.73% | 95.18% | 70.16% | 84.92% | 74.25% |
| 20-Day Relative Strength | 64.03 | 64.90 | 60.40 | 67.22 | 64.15 |
| Weighted Alpha | +172.85 | +48.12 | +32.21 | +55.22 | +21.85 |
| Today's Opinion | 100% Buy | 100% Buy | 100% Buy | 100% Buy | 100% Buy |
| Previous Opinion | 100% Buy | 100% Buy | 100% Buy | 100% Buy | 100% Buy |
| Last Month's Opinion | 100% Buy | 100% Buy | 48% Buy | 40% Buy | 88% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +14.61% since 02/05/26 | +9.28% since 02/05/26 | -0.44% since 02/05/26 | +1.63% since 02/05/26 | +0.57% since 02/05/26 |
| Low | 46.85 on 02/11/26 | 187.06 on 02/09/26 | 361.00 on 02/11/26 | 147.07 on 02/10/26 | 59.25 on 02/12/26 |
| High | 56.39 on 02/11/26 | 205.86 on 02/12/26 | 385.12 on 02/06/26 | 157.29 on 02/11/26 | 62.05 on 02/06/26 |
| 1-Month | |||||
| %Chg | +11.97% since 01/12/26 | +9.22% since 01/12/26 | +12.49% since 01/12/26 | +23.83% since 01/12/26 | +7.33% since 01/12/26 |
| Low | 44.25 on 01/20/26 | 178.08 on 01/21/26 | 319.79 on 01/13/26 | 120.22 on 01/13/26 | 53.54 on 01/21/26 |
| High | 56.39 on 02/11/26 | 205.86 on 02/12/26 | 385.12 on 02/06/26 | 157.29 on 02/11/26 | 62.05 on 02/06/26 |
| 3-Month | |||||
| %Chg | +65.91% since 11/12/25 | +16.63% since 11/12/25 | +8.90% since 11/12/25 | +23.02% since 11/12/25 | +21.96% since 11/12/25 |
| Low | 32.90 on 11/13/25 | 175.24 on 11/13/25 | 312.39 on 12/11/25 | 116.88 on 01/05/26 | 45.26 on 11/20/25 |
| High | 56.39 on 02/11/26 | 205.86 on 02/12/26 | 385.12 on 02/06/26 | 157.29 on 02/11/26 | 62.05 on 02/06/26 |
| 6-Month | |||||
| %Chg | +173.00% since 08/12/25 | +35.73% since 08/12/25 | +28.50% since 08/12/25 | +26.49% since 08/12/25 | +28.59% since 08/12/25 |
| Low | 17.11 on 09/16/25 | 145.79 on 09/25/25 | 269.77 on 09/26/25 | 108.46 on 10/02/25 | 42.52 on 10/29/25 |
| High | 56.39 on 02/11/26 | 205.86 on 02/12/26 | 385.12 on 02/06/26 | 157.29 on 02/11/26 | 62.05 on 02/06/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 1,520,071 | 317,191,712 | 197,191,760 | 188,347,648 | 121,860,176 |
| Shares Outstanding, K | 27,688 | 1,550,908 | 538,481 | 1,240,680 | 2,035,753 |
| Annual Sales | 91,280,000 | 54,073,000,000 | 36,751,000,000 | 28,754,000,000 | 48,194,000,000 |
| Annual Net Income | -145,230,000 | 7,035,000,000 | 7,711,000,000 | 480,000,000 | 7,054,000,000 |
| Last Quarter Sales | 76,320,000 | 15,191,000,000 | 9,866,000,000 | 7,769,000,000 | 12,502,000,000 |
| Last Quarter Net Income | 15,110,000 | 2,533,000,000 | 1,333,000,000 | 3,052,000,000 | 1,087,000,000 |
| 60-Month Beta | 0.35 | 0.34 | 0.46 | 0.36 | 0.29 |
| Per-Share Information | |||||
| Most Recent Earnings | 0.52 on 11/04/25 | 2.12 on 02/10/26 | 5.29 on 02/03/26 | 1.86 on 02/10/26 | 1.26 on 02/05/26 |
| Latest Earnings Date | 02/26/26 | 05/05/26 | 05/07/26 | 04/23/26 | 04/23/26 |
| Most Recent Dividend | N/A | 0.505 on 08/08/25 | 2.520 on 02/13/26 | 0.790 on 12/15/25 | 0.630 on 01/02/26 |
| Next Ex-Dividends Date | N/A | 02/20/26 | 02/13/26 | 03/13/26 | 01/02/26 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 25.28 | 16.78 | 19.12 | 9.74 |